Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | FYN | P06241 | 2/20 | 0.40 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.40 |
| ▸ | TUBB | P07437 | 1/20 | 0.40 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.40 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.40 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.40 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.40 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.40 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7463373 | 0.84 | CA9 (0.56) | CA9CA1CA2CA12CA13 | |
| SCHEMBL8656781 | 0.81 | CA9 (0.54) | CA9CA1CA2CA12CA13 | |
| SCHEMBL5189522 | 0.80 | CA9 (0.52) | CA9CA1CA2CA12CA13 | |
| SCHEMBL28163944 | 0.77 | ALDH1A1 (0.47) | CA9CA1CA2CA12CA4 | |
| SCHEMBL8660458 | 0.76 | PTGS2 (0.51) | CA9CA1CA2CA12CA13 | |
| SCHEMBL6725775 | 0.73 | CA2 (0.75) | CA9CA1CA2CA12CA13 | |
| SCHEMBL8657899 | 0.72 | CA9 (0.47) | CA9CA1CA2CA12CA13 | |
| SCHEMBL8657255 | 0.72 | CA9 (0.44) | CA9CA1CA2CA12CA13 | |
| SCHEMBL8661248 | 0.70 | PTGS2 (0.46) | CA9CA1CA2CA12BRD4 | |
| SCHEMBL29449333 | 0.70 | NPY1R (0.41) | CA9CA1CA2CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1701059-A | Chemotherapeutic agents | SINGYO LTD (AU) | 2005-11-23 | — | — | CN | disclosed |
| US-20050038248-A1 | Chemotherapeutic agents | STARPHARMA PTY LTD (AU) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038248-A1 | Chemotherapeutic agents | MKI67, PCNA, MCL1 | CA9 967/4885CA1 1339/4885CA2 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.